Eisai Biogen's Leqembi Alzheimer's drug shows benefits over three years
The newly FDA-approved Alzheimer's treatment, Leqembi, will be prepared at Abington Neurological Associates in Abington, Pennsylvania on Tuesday, November 7,…
The newly FDA-approved Alzheimer's treatment, Leqembi, will be prepared at Abington Neurological Associates in Abington, Pennsylvania on Tuesday, November 7,…
A box of the drug Victoza, manufactured by Novo Nordisk Pharmaceutical, sits on a pharmacy counter in Provo, Utah, January…
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted earnings that beat expectations…
An exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on February 5, 2024. Spencer Platt |…
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…
Kena Betancur | Corbis News | Getty Images Pfizer On Wednesday, the US drugmaker announced that its experimental gene therapy…
Fever on the surface | Getty Images Bipartisan lawmakers on Tuesday introduced a new bill that aims to crack down…
Soup Images | Lightrocket | Getty Images Pfizer On Thursday it announced it will move ahead with a once-daily version…